THCTenet Healthcare exhibits mixed signals. While fundamental metrics like profitability and revenue have shown recent strength, its valuation appears stretched. Technical indicators suggest a current downtrend, but the company operates in a critical sector with stable demand. The thematic component is neutral, lacking strong growth drivers beyond general healthcare needs.
Tenet Healthcare operates in the healthcare services sector, which is generally stable but lacks high-growth thematic drivers. Demand for its services is driven by an aging population and increasing healthcare needs, but it is not at the forefront of disruptive technological trends.
Tenet Healthcare shows strong revenue growth and improved profitability in the latest reported periods. However, its valuation ratios, particularly the P/E, are elevated when considering trailing twelve months, and the balance sheet indicates significant debt. Free cash flow generation has been inconsistent, with a large outflow in Q4 2024.
The stock has experienced a significant price decline (-6.27%) and shows weakness across multiple timeframes. Moving averages indicate a bearish trend, and oscillators are largely in oversold territory, suggesting a potential for a rebound but no clear buy signal currently.
| Factor | Score |
|---|---|
| Healthcare Demand | 70 |
| Healthcare Policy & Regulation | 40 |
| Technological Innovation in Healthcare | 30 |
| Market Consolidation | 60 |
| Operational Efficiency | 50 |
| Factor | Score |
|---|---|
| Valuation | 75 |
| Valuation | 50 |
| Profitability | 85 |
| Growth | 55 |
| Balance Sheet Health | 45 |
| Cash Flow | 60 |
| Earnings Consistency | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 35 |
| Volume Confirmation | 60 |
| Support & Resistance | 50 |
| Short-Term Oscillators | 55 |
| Candlestick Patterns | 40 |
Strong EPS Beat
The company has consistently beaten EPS estimates in recent quarters, with the latest quarter showing a surprise of 39.17%.
Low P/E Ratio
The trailing P/E ratio of 9.326 is significantly lower than historical averages and industry peers, suggesting potential undervaluation.
Significant Price Drop
The stock price has declined by -6.27% today, closing at $148.38, indicating recent negative market sentiment.
No Recent Dividend Payments
The dividend yield is 0.0%, and the last recorded dividend payment was in 2000, suggesting no current return to shareholders via dividends.
March 2000
13
Ex-Dividend Date
July 2025
22
Next Earnings Date
H: $3.76
A: $3.17
L: $2.42
H: 5.35B
A: 5.23B
L: 5.10B
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services in heart, liver, and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
194.92 USD
The 39 analysts offering 1 year price forecasts for THC have a max estimate of 238.00 and a min estimate of 159.00.